SUSAN WALKER V. BAYER CORPORATION ET AL, 96-C 5024 (N.D. III) PAYMENTS (FSM)

SR 98-03 Dated 05/98

Previous Policy

____________________________________________________________

Resources that are a result of payments from the settlement of Susan Walker v. Bayer Corporation et al, 96-c 5024 (N.D. III) which compensates hemophiliacs who contracted the Human Immunodeficiency Virus (HIV) from contaminated blood products.

Treatment: Countable Resource in the month received.

 

References: RSA 161:2, XIII; RSA 161:4-a, IV; RSA 167:4, I(a); RSA 167:7, IV; 7 CFR 273.8(c)(1)